Showing 1 - 1 results of 1 for search 'Michael Jarmin', query time: 0.03s Refine Results
  1. 1
    Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search